Aspergillus PCR Early Detection in High Risk Oncohematological Patients

NCT01742026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2022-03-31

No results posted yet for this study

Summary

ADVANCE THERAPY ASPERGILLOSIS INVASIVE BY PCR DETECTION

Conditions

Interventions

PROCEDURE

Aspergillus PCR technique

Aspergillus DNA PCR technique

PROCEDURE

Aspergillus AGA technique

Aspergillus AGA technique

Sponsors & Collaborators

  • Grupo Espanol de trasplantes hematopoyeticos y terapia celular

    lead OTHER

Principal Investigators

  • Lourdes Vazquez, MD · University of Salamanca

  • Isabel Ruiz, Md · Hospital Vall d´Hebron

  • Rocio Parody, MD · Hospital Virgen del Rocio

  • Javier Lopez, MD · Hospital Ramon y Cajal

  • Montserrat Rovira, MD · Hospital Clinic of Barcelona

  • Montserrat Batlle, MD · Germans Trias i Pujol Hospital

  • Carlos Vallejo, MD · Hospital Central de Asturias

  • Rosario Varela, MD · Hospital de A Coruña

  • Inmaculada Heras, MD · Hospital Morales Meseguer

  • Joaquin Diaz, MD · Hospital Clinico San Carlos

  • Carlos Solano, MD · Hospital Clinico de Valencia

  • Maria Teresa Olave, MD · Hospital Lozano Blesa

  • David Gallardo, MD · H. Josep Trueta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01742026 on ClinicalTrials.gov